PLUMEAZ

Pharmaceutical preparations for inhalation for the treatment of lung diseases and disorders, including, pulmonary arterial hypertension and interstitial lung diseases; Pharmaceutical preparations for inhalation for the treatment of lung infections, including, mycobacterial infections; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, cancer, endocrine diseases and disorders, metabolic diseases and disorders, and neoplastic diseases and disorders

Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung diseases and disorders, including pulmonary arterial hypertension and interstitial lung diseases; Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung infections, including, mycobacterial infections; Medical devices, namely, devices for the administration of insulin, inhaler systems comprising inhalers and cartridges for administration of pharmaceuticals, and inhalers, and cartridges for use with inhalers, all provided empty; medical devices in the nature of inhalers used to measure patient inhalation effort and to train patients in personal inhaler use, medical devices in the nature of inhalers with features for measuring respiratory effort and facilitating the training of patients in use of inhalers, medical devices in the nature of inhalers with features for the measurement of respiratory patterns of patients, medical devices included as a component of inhaler systems for medical use, namely, patient monitors for monitoring and measuring respiration, apparatus for diagnosing or treating respiratory conditions, medical devices included as a component of inhaler systems for medical use, namely, devices used to indicate dosing of medication, medical devices included as a component of inhaler systems for medical use, namely, devices used to transmit and receive data regarding inhalation, respiration, or dosage